Understanding Drug Development for Clinical Care
Am J Gastroenterol
.
2020 Sep;115(9):1351-1352.
doi: 10.14309/ajg.0000000000000683.
Authors
Eric D Shah
1
,
Yasmin G Hernandez-Barco
2
,
Kendall R Beck
3
,
Benjamin H Levy 3rd
4
;
ACG FDA-Related Matters Committee
Affiliations
1
Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
2
Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
3
Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, California, USA.
4
Division of Gastroenterology, Mount Sinai Hospital, Chicago, Illinois, USA.
PMID:
32453059
DOI:
10.14309/ajg.0000000000000683
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Clinical Trials as Topic*
Drug Development*
Gastrointestinal Diseases / drug therapy*
Humans